C World Wide Group Holding A Biogen Inc. Transaction History

C World Wide Group Holding A

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 02, 2019	SELL	$219.29 - $241.72 $9.11 Million - $10 Million	-41,551 Closed	0 $0
Q1 2019 May 03, 2019	SELL	$216.71 - $338.96 $566,479 - $886,041	-2,614 Reduced 5.92%	41,551 $9.82 Million
Q4 2018 Feb 12, 2019	SELL	$278.5 - $352.75 $4.15 Million - $5.26 Million	-14,905 Reduced 25.23%	44,165 $13.3 Million
Q3 2018 Nov 05, 2018	BUY	$293.51 - $383.83 $3.08 Million - $4.02 Million	10,484 Added 21.58%	59,070 $20.9 Million
Q1 2018 May 03, 2018	BUY	$260.13 - $367.91 $1.98 Million - $2.8 Million	7,612 Added 18.58%	48,586 $13.3 Million
Q4 2017 Feb 07, 2018	SELL	$307.64 - $344.58 $2.67 Million - $2.99 Million	-8,691 Reduced 17.5%	40,974 $13.1 Million
Q3 2017 Nov 06, 2017	BUY	$281.15 - $329.69 $14 Million - $16.4 Million	49,665	49,665 $15.6 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.